Global Genetic Analysis of Ten Thousand Patients Identifies Six New Genes Driving Severe Pregnancy Sickness

Largest study of hyperemesis gravidarum reveals six new genetic links, pointing to metabolic pathways and hormone sensitivity as keys to treating severe nausea.

By: AXL Media

Published: Apr 14, 2026, 11:40 AM EDT

Source: Information for this report was sourced from EurekAlert!

Global Genetic Analysis of Ten Thousand Patients Identifies Six New Genes Driving Severe Pregnancy Sickness - article image
Global Genetic Analysis of Ten Thousand Patients Identifies Six New Genes Driving Severe Pregnancy Sickness - article image

A Genetic Breakthrough in Maternal Health

Research led by the Keck School of Medicine of USC has significantly expanded the scientific understanding of hyperemesis gravidarum (HG), a debilitating form of pregnancy sickness that affects roughly 2% of women. In a massive genome-wide association study published on April 14, 2026, an international team analyzed DNA from 10,974 women with the condition alongside a control group of over 460,000 individuals. By including participants of European, Asian, African, and Latino ancestries, the study provides a generalizable genetic map that moves the conversation away from outdated psychological theories and firmly into the realm of biological medicine.

The Role of Hormone Sensitivity and GDF15

The study reaffirmed that the gene GDF15 remains the most significant driver of severe nausea. This gene produces a hormone that rises sharply during pregnancy, but a woman's reaction to it is dictated by her pre-pregnancy exposure. According to lead researcher Dr. Marlena Fejzo, women who carry a mutation that keeps their hormone levels low before conception are hypersensitive when levels spike during pregnancy. Conversely, those with higher baseline exposure appear more resilient. This discovery clarifies why some women experience typical morning sickness while others suffer from the persistent vomiting and malnourishment characteristic of HG.

New Metabolic and Neurological Targets

Among the six newly identified genes, TCF7L2 has emerged as a particularly intriguing target for medical researchers. Known primarily as a major risk factor for type 2 and gestational diabetes, its link to HG suggests that insulin and glucose metabolism play a larger role in pregnancy sickness than previously thought. The gene may influence GLP-1, a gut hormone that regulates both blood sugar and appetite. Furthermore, other newly identified genes are involved in brain plasticity, suggesting that the brain may actually "learn" to associate specific triggers with nausea, creating lasting aversions that worsen the patient's condition.

Categories

Topics

Related Coverage